Study of XmAb412 in Healthy Participants

NCT07713485 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Not Applicable - Healthy Adult Participants

Interventions

DRUG: XmAb412 Monoclonal Bispecific Antibody
DRUG: Placebo

Sponsor

Xencor, Inc.